http://lookfordiagnosis.com
English
Spanish
Italian
Portuguese
French
Swedish
Study Updates, Market Activity, Preclinical Data, and Oral Presentations ...
... presentation of preclinical data demonstrating the promise of DCR-PH1, the Company's therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1) - a rare inherited liver disorder that often results in progressive and severe kidney ...
MarketWatch - Thu, 03 Jul 2014 03:30


1  

Last update: April 2009
Statistics